CPX-351（Vyxeos）可导致急性髓系白血病患者出现严重皮疹——一例病例报告。
CPX-351 (Vyxeos) can cause severe rash in acute myeloid leukemia-A case report.
作者信息
Urbantat Ruth M, Popper Valentin, Menschel Elisabeth, Pfeilstöcker Michael, Forjan Ernst, Nader Alexander, Sieghart Catherine R, Keil Felix, Koller Elisabeth
机构信息
OeGK-Hanusch Krankenhaus Vienna Austria.
Medizinische Universität Vienna Austria.
出版信息
Clin Case Rep. 2021 Feb 12;9(4):1933-1936. doi: 10.1002/ccr3.3909. eCollection 2021 Apr.
Abstract
CPX-351, a promising new agent for patients with treatment-related and secondary acute myeloid leukemia can lead to a severe whole-body rash. Although severe side effects are rare, treatment should be carefully monitored at specialized centers.
摘要
CPX-351是一种有前景的治疗与治疗相关及继发性急性髓系白血病患者的新药，可能会导致严重的全身性皮疹。尽管严重副作用罕见，但在专科中心进行治疗时仍应仔细监测。
Zotero 插件